DaVita Inc. (0I7E.L)
USD 150.19
(-2.68%)
USD 150.19
(-2.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.34 Billion USD | 14.13% |
| 2022 | 2.04 Billion USD | -17.25% |
| 2021 | 2.45 Billion USD | 5.36% |
| 2020 | 2.31 Billion USD | -2.26% |
| 2019 | 2.37 Billion USD | 15.62% |
| 2018 | 2.08 Billion USD | -13.28% |
| 2017 | 2.38 Billion USD | -4.35% |
| 2016 | 2.55 Billion USD | 27.07% |
| 2015 | 1.77 Billion USD | -14.33% |
| 2014 | 2.42 Billion USD | 14.02% |
| 2013 | 2.1 Billion USD | 24.05% |
| 2012 | 1.63 Billion USD | 14.88% |
| 2011 | 1.42 Billion USD | 15.49% |
| 2010 | 1.22 Billion USD | 5.32% |
| 2009 | 1.15 Billion USD | 13.93% |
| 2008 | 1.02 Billion USD | 4.94% |
| 2007 | 1.05 Billion USD | -14.1% |
| 2006 | 912.72 Million USD | 96.36% |
| 2005 | 465.37 Million USD | 17.69% |
| 2004 | 467.79 Million USD | 3.35% |
| 2003 | 434.61 Million USD | 5.97% |
| 2002 | 448.49 Million USD | 7.47% |
| 2001 | 416.06 Million USD | 38.31% |
| 2000 | 290.87 Million USD | -8.29% |
| 1999 | 188.3 Million USD | -14.35% |
| 1998 | 303.4 Million USD | 268.36% |
| 1997 | 165.2 Million USD | 68.17% |
| 1996 | 105.7 Million USD | 180.18% |
| 1995 | 33.2 Million USD | 1.37% |
| 1994 | 21.9 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 623.14 Million USD | 8.86% |
| 2024 Q3 | 695.03 Million USD | 0.82% |
| 2024 Q2 | 676.57 Million USD | 9.98% |
| 2023 Q1 | 493.46 Million USD | 11.51% |
| 2023 Q3 | 664.71 Million USD | 12.6% |
| 2023 Q4 | 605.9 Million USD | -8.85% |
| 2023 FY | - USD | 14.13% |
| 2023 Q2 | 590.33 Million USD | 19.63% |
| 2022 Q2 | 602.6 Million USD | 18.28% |
| 2022 Q1 | 509.46 Million USD | -9.31% |
| 2022 FY | - USD | -17.25% |
| 2022 Q3 | 501.3 Million USD | -16.81% |
| 2022 Q4 | 442.52 Million USD | -11.73% |
| 2021 Q2 | 675.35 Million USD | 10.81% |
| 2021 Q1 | 609.47 Million USD | 10.95% |
| 2021 Q3 | 637.74 Million USD | -5.57% |
| 2021 Q4 | 561.79 Million USD | -11.91% |
| 2021 FY | - USD | 5.36% |
| 2020 Q3 | 599.95 Million USD | 1.16% |
| 2020 FY | - USD | -2.26% |
| 2020 Q2 | 593.09 Million USD | -3.21% |
| 2020 Q1 | 612.75 Million USD | -3.13% |
| 2020 Q4 | 549.32 Million USD | -8.44% |
| 2019 FY | - USD | 15.62% |
| 2019 Q2 | 619.77 Million USD | 15.41% |
| 2019 Q4 | 632.54 Million USD | 1.47% |
| 2019 Q1 | 537.01 Million USD | 4.39% |
| 2019 Q3 | 623.38 Million USD | 0.58% |
| 2018 Q1 | 558.06 Million USD | -4.07% |
| 2018 Q4 | 514.41 Million USD | 15.17% |
| 2018 Q2 | 567.65 Million USD | 1.72% |
| 2018 Q3 | 446.64 Million USD | -21.32% |
| 2018 FY | - USD | -13.28% |
| 2017 Q4 | 581.75 Million USD | -2.89% |
| 2017 Q3 | 599.04 Million USD | -7.09% |
| 2017 FY | - USD | -4.35% |
| 2017 Q1 | 588.95 Million USD | -4.12% |
| 2017 Q2 | 644.72 Million USD | 9.47% |
| 2016 Q1 | 614.22 Million USD | -0.78% |
| 2016 Q4 | 614.28 Million USD | -2.25% |
| 2016 Q3 | 628.39 Million USD | -4.63% |
| 2016 FY | - USD | 27.07% |
| 2016 Q2 | 658.87 Million USD | 7.27% |
| 2015 Q3 | 673.91 Million USD | 13.52% |
| 2015 Q2 | 593.63 Million USD | 566.25% |
| 2015 Q1 | 89.1 Million USD | -85.29% |
| 2015 FY | - USD | -14.33% |
| 2015 Q4 | 619.06 Million USD | -8.14% |
| 2014 Q3 | 585.48 Million USD | 9.57% |
| 2014 Q1 | 585.5 Million USD | -6.63% |
| 2014 Q4 | 605.56 Million USD | 3.43% |
| 2014 FY | - USD | 14.02% |
| 2014 Q2 | 534.34 Million USD | -8.74% |
| 2013 FY | - USD | 24.05% |
| 2013 Q4 | 627.1 Million USD | 22.44% |
| 2013 Q3 | 512.19 Million USD | -13.82% |
| 2013 Q2 | 594.29 Million USD | 102.58% |
| 2013 Q1 | 293.36 Million USD | -40.1% |
| 2012 Q3 | 421.44 Million USD | 4.4% |
| 2012 Q1 | 394.06 Million USD | -2.24% |
| 2012 Q2 | 403.68 Million USD | 2.44% |
| 2012 Q4 | 489.73 Million USD | 16.2% |
| 2012 FY | - USD | 14.88% |
| 2011 Q2 | 311.51 Million USD | 4.38% |
| 2011 Q4 | 403.09 Million USD | 4.29% |
| 2011 FY | - USD | 15.49% |
| 2011 Q1 | 298.43 Million USD | -5.4% |
| 2011 Q3 | 386.53 Million USD | 24.08% |
| 2010 FY | - USD | 5.32% |
| 2010 Q4 | 315.47 Million USD | 0.13% |
| 2010 Q3 | 315.07 Million USD | 4.77% |
| 2010 Q2 | 300.71 Million USD | 0.98% |
| 2010 Q1 | 297.78 Million USD | 0.75% |
| 2009 FY | - USD | 13.93% |
| 2009 Q4 | 295.57 Million USD | -2.07% |
| 2009 Q3 | 301.81 Million USD | 2.61% |
| 2009 Q2 | 294.13 Million USD | 5.91% |
| 2009 Q1 | 277.72 Million USD | 4.5% |
| 2008 Q2 | 255.45 Million USD | 4.41% |
| 2008 Q1 | 244.67 Million USD | 1.39% |
| 2008 FY | - USD | 4.94% |
| 2008 Q4 | 265.76 Million USD | 2.07% |
| 2008 Q3 | 260.37 Million USD | 1.92% |
| 2007 Q1 | 235.91 Million USD | -53.52% |
| 2007 Q4 | 241.32 Million USD | -5.5% |
| 2007 Q3 | 255.36 Million USD | 4.08% |
| 2007 Q2 | 245.34 Million USD | 4.0% |
| 2007 FY | - USD | -14.1% |
| 2006 FY | - USD | 96.36% |
| 2006 Q4 | 507.51 Million USD | 130.34% |
| 2006 Q3 | 220.33 Million USD | 4.67% |
| 2006 Q2 | 210.49 Million USD | 5.2% |
| 2006 Q1 | 200.09 Million USD | 12.73% |
| 2005 Q2 | 136.23 Million USD | 6.68% |
| 2005 FY | - USD | 17.69% |
| 2005 Q4 | 177.49 Million USD | 28.29% |
| 2005 Q3 | 138.35 Million USD | 1.56% |
| 2005 Q1 | 127.69 Million USD | 0.29% |
| 2004 FY | - USD | 3.35% |
| 2004 Q4 | 127.33 Million USD | -4.19% |
| 2004 Q3 | 132.89 Million USD | 13.85% |
| 2004 Q2 | 116.72 Million USD | 0.92% |
| 2004 Q1 | 115.66 Million USD | -22.95% |
| 2003 Q3 | 114.54 Million USD | 30.96% |
| 2003 Q2 | 100.72 Million USD | 4.0% |
| 2003 FY | - USD | 5.97% |
| 2003 Q1 | 96.77 Million USD | -30.57% |
| 2003 Q4 | 141.17 Million USD | 14.81% |
| 2002 Q2 | 96.6 Million USD | -88.77% |
| 2002 Q1 | 804.99 Million USD | 701.17% |
| 2002 Q3 | 127.59 Million USD | 39.07% |
| 2002 FY | - USD | 7.47% |
| 2002 Q4 | 137.07 Million USD | 9.33% |
| 2001 Q3 | 123.14 Million USD | 26.43% |
| 2001 FY | - USD | 38.31% |
| 2001 Q1 | 101.61 Million USD | 29.79% |
| 2001 Q4 | 101.38 Million USD | -16.68% |
| 2001 Q2 | 97.05 Million USD | -4.32% |
| 2000 Q4 | 79.08 Million USD | 2.44% |
| 2000 Q1 | 68.03 Million USD | -45.02% |
| 2000 Q3 | 76.83 Million USD | -9.49% |
| 2000 FY | - USD | -8.29% |
| 2000 Q2 | 66.92 Million USD | 25.04% |
| 1999 Q2 | 38.1 Million USD | -42.57% |
| 1999 FY | - USD | -14.35% |
| 1999 Q1 | 96.9 Million USD | 77.04% |
| 1999 Q4 | -396 Thousand USD | 73.64% |
| 1999 Q3 | 66.7 Million USD | 27.14% |
| 1998 Q1 | 69.7 Million USD | 409.18% |
| 1998 FY | - USD | 268.36% |
| 1998 Q4 | 69.9 Million USD | -40.4% |
| 1998 Q3 | 90.6 Million USD | 13.68% |
| 1998 Q2 | 80.3 Million USD | -50.47% |
| 1997 FY | - USD | 68.17% |
| 1997 Q3 | 59.4 Million USD | 11.79% |
| 1997 Q2 | 25.1 Million USD | 17.7% |
| 1997 Q1 | 21.3 Million USD | 6.63% |
| 1997 Q4 | 32.3 Million USD | 14.91% |
| 1996 Q1 | 12 Million USD | 11.54% |
| 1996 Q2 | 15.2 Million USD | 20.69% |
| 1996 Q3 | 17.4 Million USD | 21.43% |
| 1996 Q4 | 19.5 Million USD | 15.29% |
| 1996 FY | - USD | 180.18% |
| 1995 Q4 | 10.4 Million USD | 13.04% |
| 1995 Q3 | 9.2 Million USD | 116.14% |
| 1995 FY | - USD | 1.37% |
| 1995 Q2 | -57 Million USD | -329.84% |
| 1995 Q1 | 24.8 Million USD | 0.4% |
| 1994 Q4 | 24.7 Million USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q3 | 24.7 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 2379.32% |
| Accuray Incorporated | 9 Million USD | -25945.577% |
| Align Technology, Inc. | 799.03 Million USD | -193.659% |
| Elevance Health Inc. | 10.49 Billion USD | 77.632% |
| AxoGen, Inc. | -13.32 Million USD | 17705.387% |
| Boston Scientific Corporation | 3.61 Billion USD | 35.055% |
| CVS Health Corporation | 18.17 Billion USD | 87.092% |
| Cardinal Health, Inc. | 1.97 Billion USD | -18.627% |
| Centene Corporation | -463 Million USD | 606.792% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 81.555% |
| Hologic, Inc. | 1.29 Billion USD | -81.025% |
| Humana Inc. | -561 Million USD | 518.261% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -92.7% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -73.888% |
| Masimo Corporation | 236.7 Million USD | -891.316% |
| McKesson Corporation | 4.66 Billion USD | 49.723% |
| Patterson Companies, Inc. | 374.75 Million USD | -526.126% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -35.476% |
| ResMed Inc. | 1.6 Billion USD | -46.623% |
| Henry Schein, Inc. | 943 Million USD | -148.828% |
| Teladoc Health, Inc. | 153.99 Million USD | -1423.696% |
| Universal Health Services, Inc. | 1.74 Billion USD | -34.589% |
| Veeva Systems Inc. | 429.33 Million USD | -446.532% |
| Baxter International Inc. | 2.77 Billion USD | 15.474% |
| Becton, Dickinson and Company | 4.27 Billion USD | 45.112% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 1.99% |
| Danaher Corporation | 7.49 Billion USD | 68.71% |
| Stryker Corporation | 5.16 Billion USD | 54.526% |
| Medtronic plc | 9.05 Billion USD | 74.09% |